
|Articles|January 1, 2002
Botulinum toxin-A(ccuracy)
Munich - Dermatologists can objectively assess a patient's response to botulinum toxin-A treatment by using a digital camera and appropriate software, according to research recently published by Mark Heckmann, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The “6-7” Advances for Dermatologists to Look Forward to in 2026
2
Quoin Targets World’s First Approval for Netherton Syndrome Therapy in Saudi Arabia
3
Obagi Launches ALOHA Program to Capture Real-World Insights in Aesthetic Injectables
4
Exploring Type 2 Inflammation and Psoriasis Management at Horizons in Advanced Practice
5



















